Marex Group plc Stock Price, News & Analysis

Marex Group (Nasdaq: MRX) reported Q3 2025 results on November 6, 2025: Q3 revenue $484.6m (+24% year‑on‑year) and Adjusted Profit Before Tax $100.5m (+25% y/y). Q3 YTD revenue was $1,452.0m (+23%) and Adjusted PBT YTD $303.2m (+26%).

Key drivers included Clearing (average client balances $13.3bn, +4%), a 52% rise in Agency and Execution revenue, Prime Services expansion, and record Hedging & Investment Solutions trading. Reported costs rose 24% to $380.3m. The board declared a $0.15 per‑share Q3 dividend; S&P reaffirmed an investment‑grade credit rating on September 23, 2025.

Marex Group (NASDAQ: MRX) will release its fiscal 2025 third quarter results before market open on Thursday, November 6, 2025. The earnings release and supplementary materials will be posted in the Investors section of the Marex website at https://ir.marex.com/.

A live conference call to discuss the results is scheduled for 9:00 AM ET on November 6, 2025; live access is available via the provided webcast link. Contact details for investor enquiries and PR advisors are included in the announcement.

Marex Group (NASDAQ: MRX) agreed to acquire Geneva-based fixed income market maker Valcourt SA, adding 700 clients and specialist capabilities in high-yield, subordinated, emerging markets, private, illiquid and sustainable debt.

The transaction aims to expand Marex’s fixed income distribution into the Swiss institutional community and diversify earnings by offering Valcourt clients access to Marex’s broader platform. The deal is subject to regulatory approval and is expected to close in the first half of 2026.

Marex (NASDAQ: MRX) announced that directors and officers purchased ordinary shares in the open market between October 10–14, 2025. Key purchases include CEO Ian Lowitt buying 32,465 shares (total 2,615,016), Paolo Tonucci buying 30,000 shares (total 1,108,342), Non-Executive Chairman Robert Pickering buying 2,700 shares (total 20,594) and Board member Konstantin Graf von Schweinitz buying 7,100 shares (total 14,993). Former board members Sir Jeremy Isaacs and Roger Nagioff each bought 35,000 shares.

Management says the purchases reflect confidence in Marex’s growth trajectory and notes the executive leadership team collectively owns more than 7% of the company.

Marex (NASDAQ: MRX) announced on October 13, 2025 that Chief Executive Officer Ian Lowitt purchased 32,465 ordinary shares in the open market on October 10, 2025, increasing his total holding to 2,615,016 ordinary shares.

The transaction was an open‑market purchase by the CEO and updates insider ownership levels disclosed by the company.

Marex (Nasdaq: MRX) provided a preliminary unaudited Q3 2025 trading update reporting estimated revenue $475–$485m (midpoint +23% YoY) and Adjusted profit before tax $96–$101m (midpoint +22% YoY). Management said Adjusted ROE ~27% and Adjusted PBT margin ~21%. Average clearing client balances rose 4% to $13.3bn and the firm reported a CFTC-reported record of >$10bn in US client assets in October. Results are preliminary, subject to quarter-end close and audit; full Q3 results and a conference call are scheduled for 6 November 2025.

Marex Group plc (NASDAQ: MRX) announced that S&P Global Ratings has assigned a first-time BBB rating with a stable outlook to its US subsidiary, Marex Capital Markets Inc. (MCMI). The rating reflects MCMI's core status within Marex Group and its strategic importance to the company's global operations.

Additionally, S&P affirmed Marex Group's BBB- rating with a stable outlook, citing the company's strong performance and capitalization. The new MCMI rating is expected to facilitate increased client activity in the US market.